Dr. Philip Philip on Choosing the Right Treatment for Advanced Pancreatic Cancer Patients
Philip Philip, MD, PhD, professor of oncology at Karmanos Cancer Center, Wayne State University School of Medicine, on treatment options for patients with advanced pancreatic cancer.
Philip Philip, MD, PhD, professor of oncology at Karmanos Cancer Center, Wayne State University School of Medicine, on treatment options for patients with advanced pancreatic cancer. Philip says treating a patient with advanced pancreatic cancer as soon as the diagnosis is made is usually the best option and not waiting for a later date to try "better" treatments.
Philip adds that while some patients will do well on different treatments, some will never be able to tolerate a combination therapy. He adds that the two biggest treatments for advanced pancreatic cancer are a combinaiton of gemcitabine and paclitaxel, as well as the folfirinox regiment.
Enasidenib Shows Promise as Post-Transplant Maintenance in IDH2-Mutated AML
January 7th 2025Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic stem cell transplant maintenance therapy for IDH2-mutated acute myeloid leukemia treatment.
Read More
Could Triapine With Lutetium 177 Dotatate Improve Outcomes for Neuroendocrine Tumors?
December 30th 2024Aman Chauhan, MD, highlights an ongoing phase 2 trial exploring the combination of triapine, a radiation sensitizer, with lutetium 177 dotatate for treating well-differentiated somatostatin receptor–-positive neuroendocrine tumors.
Read More
